Wall Street Zen lowered shares of Cimpress (NASDAQ:CMPR – Free Report) from a strong-buy rating to a buy rating in a research note published on Saturday. Other analysts also recently issued research reports about the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Cimpress in a report on Monday, December 29th. Barrington […]

Wall Street Zen lowered shares of Amgen (NASDAQ:AMGN – Free Report) from a buy rating to a hold rating in a research note published on Saturday. AMGN has been the subject of a number of other research reports. Truist Financial boosted their price objective on Amgen from $318.00 to $319.00 and gave the company a […]

Wall Street Zen lowered shares of Lunai Bioworks (NASDAQ:LNAI – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday morning. Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Lunai Bioworks in a report on Monday, December 29th. One investment analyst has rated […]

Context Therapeutics (NASDAQ:CNTX – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Monday. A number of other research analysts also recently weighed in on the stock. HC Wainwright upped their price objective on shares of Context Therapeutics […]

Wall Street Zen lowered shares of TG Therapeutics (NASDAQ:TGTX – Free Report) from a buy rating to a hold rating in a research note issued to investors on Saturday. Several other analysts also recently weighed in on the stock. JPMorgan Chase & Co. lowered their price target on shares of TG Therapeutics from $49.00 to […]